2018
DOI: 10.1371/journal.pone.0202165
|View full text |Cite
|
Sign up to set email alerts
|

Minodronate treatment improves low bone mass and reduces progressive thoracic scoliosis in a mouse model of adolescent idiopathic scoliosis

Abstract: Recent studies have shown an association between osteopenia and adolescent idiopathic scoliosis (AIS) and implied that osteopenia plays a causative role in AIS development. This study aimed to determine if minodronate (MIN) treatment could prevent curve progression by increasing bone mass in a thoracic restraint (TR) mouse model, which develops causes the development of thoracic scoliosis similar to human AIS. A total of 100 young female C57BL6J mice were divided into four groups: (1) control with vehicle (CON… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 50 publications
(50 reference statements)
0
5
0
Order By: Relevance
“…Despite the unclear pathomechanism on how the abnormal bone qualities could contribute to the initiation or progression, or both, of AIS, the observed close clinical association and prognostic value of low bone mass have been supported by our initial pilot studies on the effect of improving bone quality in reducing curve progression (ClinicalTrials.gov: NCT01103115). A recent proof‐of‐concept study demonstrated the beneficial effect of minodronate (a third‐generation bisphosphonate) on reducing curve progression in a scoliosis mouse model, suggesting a novel therapeutic option for AIS (60). However, because of the unclear long‐term effect of anti‐osteoporotic drugs on growing adolescents, our group have also explored the clinical effect of vibration therapy on bone mass in AIS (61).…”
Section: Discussionmentioning
confidence: 99%
“…Despite the unclear pathomechanism on how the abnormal bone qualities could contribute to the initiation or progression, or both, of AIS, the observed close clinical association and prognostic value of low bone mass have been supported by our initial pilot studies on the effect of improving bone quality in reducing curve progression (ClinicalTrials.gov: NCT01103115). A recent proof‐of‐concept study demonstrated the beneficial effect of minodronate (a third‐generation bisphosphonate) on reducing curve progression in a scoliosis mouse model, suggesting a novel therapeutic option for AIS (60). However, because of the unclear long‐term effect of anti‐osteoporotic drugs on growing adolescents, our group have also explored the clinical effect of vibration therapy on bone mass in AIS (61).…”
Section: Discussionmentioning
confidence: 99%
“…It is a three-dimensional deformity of the coronal, sagittal, and horizontal surfaces of the spine. Patients with thoracic scoliosis have a higher incidence of neck pain, back pain and low back pain due to the presence of coronal plane deformity and reduced thoracic kyphosis [2] and abnormal spine biomechanics [3,4] . The loss of physiological curvature leads to pathological changes in the spine and accelerated disc degeneration, affecting the health-related quality of life of patients [5] .…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have reported that parathyroid hormone and bisphosphonate treatments exhibit preventive effects in mouse models of scoliosis and that decreased BMD is a factor in scoliosis formation. 28,29 However, in the Sko mice, BMD loss appeared after the onset and progression of scoliosis (scoliosis was observed from 1 or 2 weeks and rapidly progressed by 6 weeks, whereas BMD loss developed from 6 weeks), and no significant differences were observed in the bone microstructure between the right and left sides of the bone trabeculae. Therefore, reduced BMD and bone quality may not be the causes of the onset and progression of scoliosis in the Sko mice.…”
Section: Characteristics Of Scoliosis In Mice • Handa Et Almentioning
confidence: 98%